reference/31575544

Predicate	Object
contentType	Journal Article
endingPage	595
issn	1179-2027 1170-7690
issueIdentifier	7
pageRange	585-595
publicationName	PharmacoEconomics
startingPage	585
bibliographicCitation	Latour-Perez J, de-Miguel-Balsa E. Cost effectiveness of fondaparinux in non-ST-elevation acute coronary syndrome. Pharmacoeconomics. 2009;27(7):585–95. doi: 10.2165/11310120-000000000-00000. PMID: 19663529.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58fd8036ee0f007e34a63a2f55b79869 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_676428f1d020739502e9b628e24285fd
date	200907
identifier	https://doi.org/10.2165/11310120-000000000-00000 https://pubmed.ncbi.nlm.nih.gov/19663529
isPartOf	https://portal.issn.org/resource/ISSN/1170-7690 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21262 https://portal.issn.org/resource/ISSN/1179-2027
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Cost Effectiveness of Fondaparinux in Non-ST-Elevation Acute Coronary Syndrome
discusses	http://id.nlm.nih.gov/mesh/M0017249 http://id.nlm.nih.gov/mesh/M0001380 http://id.nlm.nih.gov/mesh/M0403648
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282448 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136116304 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248153327

Total number of triples: 32.